FDA, FTC Issue Joint Warning Letter To Web Site Offering Fraudulent H1N1 Flu Supplements
On October 15, 2009, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued a joint warning letter to a Web site marketing fraudulent supplements that claim to help prevent the spread of the 2009 H1N1 influenza virus. The warning letter, the first to be issued jointly by the agencies, advises the owners of the site that they must discontinue the fraudulent marketing of their product or face legal action.
Related Posts
Tags: efficacy, fraudulent, h1n1, issue, joint, letter, offering, site, supplements, warning
This entry was posted on Tuesday, October 20th, 2009 at 7:10 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
